Segment Reporting

In September 2015, it was decided to introduce a new organizational structure effective January 1, 2016, in line with Bayer’s focus on the Life Science businesses. The former Bayer HealthCare subgroup was dissolved and the Radiology business is now assigned to the Pharmaceuticals Division. The Consumer Health Division now consists entirely of the Consumer Care business. Animal Health has become a separate reportable segment. The Bayer CropScience subgroup is now the Crop Science Division. Since January 1, 2016, therefore, the Bayer Group has comprised the five reportable segments Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro.

The following table shows the reconciliation of EBITDA before special items of the above-mentioned segments and the reconciliation to income before income taxes of the Group:

Reconciliation of Segments’ EBITDA Before Special Items to Group Income Before Income Taxes

 

 

Q2 2015

Q2 2016

 

H1 2015

H1 2016

 

 

€ million

€ million

 

€ million

€ million

2015 figures restated

1

For definition see Interim Group Management Report, “Calculation of EBIT(DA) Before Special Items.”

EBITDA before special items of segments

 

2,987

3,074

 

6,058

6,486

EBITDA before special items of Corporate Functions and Consolidation

 

(99)

(20)

 

(248)

(45)

EBITDA before special items1

 

2,888

3,054

 

5,810

6,441

Depreciation, amortization and impairment losses before special items of segments

 

(808)

(811)

 

(1,560)

(1,604)

Depreciation, amortization and impairment losses before special items of Corporate Functions and Consolidation

 

(2)

(1)

 

(3)

(3)

Depreciation, amortization and impairment losses before special items

 

(810)

(812)

 

(1,563)

(1,607)

EBIT before special items of segments

 

2,179

2,263

 

4,498

4,882

EBIT before special items of Corporate Functions and Consolidation

 

(101)

(21)

 

(251)

(48)

EBIT before special items1

 

2,078

2,242

 

4,247

4,834

Special items of segments

 

(248)

(95)

 

(488)

(365)

Special items of Corporate Functions and Consolidation

 

(7)

(9)

 

(11)

(11)

Special items1

 

(255)

(104)

 

(499)

(376)

EBIT of segments

 

1,931

2,168

 

4,010

4,517

EBIT of Corporate Functions and Consolidation

 

(108)

(30)

 

(262)

(59)

EBIT1

 

1,823

2,138

 

3,748

4,458

Financial result

 

(287)

(314)

 

(561)

(629)

Income before income taxes

 

1,536

1,824

 

3,187

3,829